BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34333033)

  • 21. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
    Amelio P; Portevin D; Hella J; Reither K; Kamwela L; Lweno O; Tumbo A; Geoffrey L; Ohmiti K; Ding S; Pantaleo G; Daubenberger C; Perreau M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease.
    Mutavhatsindi H; van der Spuy GD; Malherbe ST; Sutherland JS; Geluk A; Mayanja-Kizza H; Crampin AC; Kassa D; Howe R; Mihret A; Sheehama JA; Nepolo E; Günther G; Dockrell HM; Corstjens PLAM; Stanley K; Walzl G; Chegou NN;
    Front Immunol; 2021; 12():607827. PubMed ID: 33717089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response.
    Jacobs R; Maasdorp E; Malherbe S; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
    PLoS One; 2016; 11(8):e0160546. PubMed ID: 27487181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Activation by Mycobacterium tuberculosis in HIV-Infected and -Uninfected Subjects.
    Wyndham-Thomas C; Corbière V; Selis E; Payen MC; Goffard JC; Van Vooren JP; Mascart F; Dirix V
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):103-111. PubMed ID: 27532475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific chemokine profiles as biomarkers for detecting
    Ren W; Ma Z; Li Q; Liu R; Ma L; Yao C; Shang Y; Zhang X; Gao M; Li S; Pang Y
    Front Immunol; 2024; 15():1359555. PubMed ID: 38510248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis.
    Qiu X; Wang H; Tang Y; Su X; Ge L; Qu Y; Mu D
    Ann Med; 2020 Nov; 52(7):376-385. PubMed ID: 32700645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Kamakia R; Kiazyk S; Waruk J; Meyers A; Ochanda J; Ball TB; Oyugi J
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):278-285. PubMed ID: 28225338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    Sudbury EL; Clifford V; Messina NL; Song R; Curtis N
    J Infect; 2020 Dec; 81(6):873-881. PubMed ID: 33007340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection.
    Namuganga AR; Nsereko M; Bagaya BS; Mayanja-Kizza H; Chegou NN
    Immunol Lett; 2023 Jan; 253():8-18. PubMed ID: 36463987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
    Tebruegge M; Ritz N; Donath S; Dutta B; Forbes B; Clifford V; Zufferey C; De Rose R; Robins-Browne RM; Hanekom W; Graham SM; Connell T; Curtis N
    Front Immunol; 2019; 10():431. PubMed ID: 31024518
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY; Park JH; Kim MC; Cha HH; Jeon NY; Park SY; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect; 2018 Oct; 77(4):314-320. PubMed ID: 29746954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB.
    Wang S; Li Y; Shen Y; Wu J; Gao Y; Zhang S; Shao L; Jin J; Zhang Y; Zhang W
    J Transl Med; 2018 Jul; 16(1):206. PubMed ID: 30029650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.